Key result
Factor Xa cleaves and inactivates anticoagulant protein S, suggesting a novel procoagulant mechanism.
Why the study?
The mechanism by which factor Xa may exert procoagulant effects through cleavage and inactivation of protein S was not fully understood.
Factor Xa-mediated cleavage and inactivation of protein S represents a potential mechanism for its procoagulant effect beyond initial clot formation.
Identifies a potential procoagulant feedback loop; leaves open its relevance to human thrombosis or therapeutic targeting.
Human factor Xa specifically cleaves the anticoagulant protein S within the thrombin-sensitive domain. Amino-terminal amino acid sequencing of the heavy chain cleavage product indicates cleavage of protein S by factor Xa at Arg60, a site that is distinct from those utilized by alpha-thrombin. Cleavage by factor Xa is unaffected by the presence of hirudin and is completely blocked by tick-anticoagulant-peptide and D-Glu-Gly-Arg-chloromethyl ketone, the latter two being specific inhibitors of factor Xa. The cleavage requires the presence of phospholipid and Ca2+, and is markedly inhibited by the presence of factor Va. Factor Xa-cleaved protein S no longer possesses its activated protein C-dependent or -independent anticoagulant activity, as measured in a factor VIII-based activated partial thromboplastin time clot assay. The apparent binding constant for protein S binding to phospholipid (Kd approximately 4 nM +/- 1.0) is unaffected by factor Xa or thrombin cleavage, suggesting that the loss of anticoagulant activity resulting from cleavage is not primarily due to the loss of membrane binding ability. Cleavage and inactivation of protein S by factor Xa may be an additional way in which factor Xa exerts its procoagulant effect, after the initial stages of clot formation.
No takes yet. Share an insight, caveat, or question.
Long et al. (1998) studied this question. Factor Xa was evaluated on Protein S cleavage and anticoagulant activity. Factor Xa specifically cleaves and inactivates anticoagulant protein S at Arg60 without altering its phospholipid binding affinity (Kd ~4 nM), suggesting a novel procoagulant mechanism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: